Skip to main content
Hims & HersLinkedIn

Hims works with Eli Lilly to expand Zepbound and Foundayo access through unified care.

Source: Autobound Signal API · 57 signals tracked for Hims & Hers · updated

Get Hims & Hers' live signals in Claude or ChatGPT, or by API

AskWhat changed at Hims & Hers this week? Use Autobound signals for hims.com.

Source

LinkedInNov 6, 2026
likes
362
comments
3

Post

We’re working with Eli Lilly and Company to expand access to Zepbound and Foundayo. No more switching to third-party platforms, no more split payments. Just one, unified care experience that is simple, straightforward, and personal. Read more, including important info: https://lnkd.in/g3zJcQ3p

linkedin.com/posts/hims-%26-hers_lilly-and-hims-hers-expand-access-to...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

More LinkedIn signals at other companies

The full record

From the Signal API record

Topics and mentions

Tags

  • Partnership
  • Pharmaceuticals

Initiatives

  • unified care platform expansion with Lilly

Technologies named

  • Foundayo
  • Zepbound

Extraction

Detected
Nov 6, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Hims & Hers and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Hims & Hers this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f67587d6-f974-414b-8e63-8407f25c6f2a returns this record as JSON. POST /v1/companies/enrich returns every signal for hims.com.

{
  "signal_id": "f67587d6-f974-414b-8e63-8407f25c6f2a",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-11-06T11:49:16.866+00:00",
  "company": {
    "name": "Hims & Hers",
    "domain": "hims.com"
  },
  "data": {
    "tags": [
      "Partnership",
      "Pharmaceuticals"
    ],
    "summary": "Hims works with Eli Lilly to expand Zepbound and Foundayo access through unified care.",
    "post_url": "https://www.linkedin.com/posts/hims-%26-hers_lilly-and-hims-hers-expand-access-to-fda-approved-activity-7524437749894893568-E-Py",
    "num_likes": 362,
    "post_text": "We’re working with Eli Lilly and Company to expand access to Zepbound and Foundayo.\n\nNo more switching to third-party platforms, no more split payments. Just one, unified care experience that is simple, straightforward, and personal. \n\nRead more, including important info: https://lnkd.in/g3zJcQ3p",
    "initiatives": [
      {
        "topic": "unified care platform expansion with Lilly",
        "urgency": 0.6
      }
    ],
    "posted_date": "2026-11-06T11:49:16.866Z",
    "num_comments": 3,
    "technologies_mentioned": [
      {
        "name": "Foundayo",
        "status": "considering"
      },
      {
        "name": "Zepbound",
        "status": "considering"
      }
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.